Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Bio Path Holdings Inc
BPTHCurrent price
1.77 USD
+0.054 USD (+3.16%)
Last closed
1.72 USD
Company
www.biopathholdings.com
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
3 765 234 USD
Yield for 12 month
+67.39 %
1Y
3Y
5Y
10Y
15Y
BPTH
Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. It is also developing BP1001-A that is in Phase I clinical trial for the treatment of solid tumors; Liposomal Bcl-2 (BP1002), which is in Phase I clinical trial for the treatment of refractory/relapsed lymphoma and chronic lymphocytic leukemia; and Liposomal STAT3 (BP1003) for treating pancreatic cancer, non-small cell lung cancer, and AML. The company was founded in 2007 and is based in Bellaire, Texas. Address: 4710 Bellaire Boulevard, Bellaire, TX, United States, 77401
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
20 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
+274 000 USD
Current Year
-178 000 USD
Last Year
-178 000 USD
Current Quarter
-47 000 USD
Last Quarter
+233 000 USD
Key Figures BPTH
1 year
3 years
5 years
10 years
EBITDA
-14 164 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-138.36 %
PEG Ratio
–
Return On Equity TTM
-430.79 %
Wall Street Target Price
20 USD
Revenue TTM
–
Book Value
-3.48 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-25.26 USD
Diluted Eps TTM
-25.26 USD
Most Recent Quarter
I 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics BPTH
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History BPTH
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:20
Payout Ratio
–
Last Split Date
23.02.2024
Dividend Date
18.01.2019
Stock Valuation BPTH
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-0.0868
Price Book MRQ
5.2133
Financials BPTH
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators BPTH
For 52 weeks
1.59 USD
23 USD
50 Day MA
2.18 USD
Shares Short Prior Month
82 583
200 Day MA
6.57 USD
Short Ratio
0.05
Shares Short
145 386
Short Percent
6.99 %
BeatStart